Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy with or without Pembrolizumab in First Line Metastatic Squamous Non-small Cell Lung Cancer Subjects.
Phase: 3Phase III in Spain, 2Phase II, 1Phase I